newsfilter
← Latest News
GlobeNewswire·

Neoleukin Therapeutics Announces Second Quarter 2022 Financial Results & Provides Corporate Update

SEATTLE, Aug. 09, 2022 (GLOBE NEWSWIRE) -- Neoleukin Therapeutics, Inc., "Neoleukin" (NASDAQ:NLTX), a biopharmaceutical company utilizing sophisticated computational methods to design de novo protein therapeutics, today announced financial results for